Global Rotavirus Infections Drug Sales Market Report 2021

Global Rotavirus Infections Drug Sales Market Report 2021

Table of Contents
1 Rotavirus Infections Drug Market Overview
1.1 Rotavirus Infections Drug Product Scope
1.2 Rotavirus Infections Drug Segment by Type
1.2.1 Global Rotavirus Infections Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 RV-3BB
1.2.3 RV-625
1.2.4 UMN-2001
1.2.5 Rotavac-5C
1.2.6 Others
1.3 Rotavirus Infections Drug Segment by Application
1.3.1 Global Rotavirus Infections Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Rotavirus Infections Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Rotavirus Infections Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Rotavirus Infections Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Rotavirus Infections Drug Price Trends (2016-2027)
2 Rotavirus Infections Drug Estimates and Forecasts by Region
2.1 Global Rotavirus Infections Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Rotavirus Infections Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Rotavirus Infections Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Rotavirus Infections Drug Revenue Market Share by Region (2016-2021)
2.3 Global Rotavirus Infections Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Rotavirus Infections Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Rotavirus Infections Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Rotavirus Infections Drug Estimates and Projections (2016-2027)
2.4.2 Europe Rotavirus Infections Drug Estimates and Projections (2016-2027)
2.4.3 China Rotavirus Infections Drug Estimates and Projections (2016-2027)
2.4.4 Japan Rotavirus Infections Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Rotavirus Infections Drug Estimates and Projections (2016-2027)
2.4.6 India Rotavirus Infections Drug Estimates and Projections (2016-2027)
3 Global Rotavirus Infections Drug Competition Landscape by Players
3.1 Global Top Rotavirus Infections Drug Players by Sales (2016-2021)
3.2 Global Top Rotavirus Infections Drug Players by Revenue (2016-2021)
3.3 Global Rotavirus Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rotavirus Infections Drug as of 2020)
3.4 Global Rotavirus Infections Drug Average Price by Company (2016-2021)
3.5 Manufacturers Rotavirus Infections Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Rotavirus Infections Drug Market Size by Type
4.1 Global Rotavirus Infections Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Rotavirus Infections Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Rotavirus Infections Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Rotavirus Infections Drug Price by Type (2016-2021)
4.2 Global Rotavirus Infections Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Rotavirus Infections Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Rotavirus Infections Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Rotavirus Infections Drug Price Forecast by Type (2022-2027)
5 Global Rotavirus Infections Drug Market Size by Application
5.1 Global Rotavirus Infections Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Rotavirus Infections Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Rotavirus Infections Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Rotavirus Infections Drug Price by Application (2016-2021)
5.2 Global Rotavirus Infections Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Rotavirus Infections Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Rotavirus Infections Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Rotavirus Infections Drug Price Forecast by Application (2022-2027)
6 North America Rotavirus Infections Drug Market Facts & Figures
6.1 North America Rotavirus Infections Drug Sales by Company
6.1.1 North America Rotavirus Infections Drug Sales by Company (2016-2021)
6.1.2 North America Rotavirus Infections Drug Revenue by Company (2016-2021)
6.2 North America Rotavirus Infections Drug Sales Breakdown by Type
6.2.1 North America Rotavirus Infections Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Rotavirus Infections Drug Sales Breakdown by Type (2022-2027)
6.3 North America Rotavirus Infections Drug Sales Breakdown by Application
6.3.1 North America Rotavirus Infections Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Rotavirus Infections Drug Sales Breakdown by Application (2022-2027)
7 Europe Rotavirus Infections Drug Market Facts & Figures
7.1 Europe Rotavirus Infections Drug Sales by Company
7.1.1 Europe Rotavirus Infections Drug Sales by Company (2016-2021)
7.1.2 Europe Rotavirus Infections Drug Revenue by Company (2016-2021)
7.2 Europe Rotavirus Infections Drug Sales Breakdown by Type
7.2.1 Europe Rotavirus Infections Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Rotavirus Infections Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Rotavirus Infections Drug Sales Breakdown by Application
7.3.1 Europe 121 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 121 Sales Breakdown by Application (2022-2027)
8 China Rotavirus Infections Drug Market Facts & Figures
8.1 China Rotavirus Infections Drug Sales by Company
8.1.1 China Rotavirus Infections Drug Sales by Company (2016-2021)
8.1.2 China Rotavirus Infections Drug Revenue by Company (2016-2021)
8.2 China Rotavirus Infections Drug Sales Breakdown by Type
8.2.1 China Rotavirus Infections Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Rotavirus Infections Drug Sales Breakdown by Type (2022-2027)
8.3 China Rotavirus Infections Drug Sales Breakdown by Application
8.3.1 China 145 Sales Breakdown by Application (2016-2021)
8.3.2 China 145 Sales Breakdown by Application (2022-2027)
9 Japan Rotavirus Infections Drug Market Facts & Figures
9.1 Japan Rotavirus Infections Drug Sales by Company
9.1.1 Japan Rotavirus Infections Drug Sales by Company (2016-2021)
9.1.2 Japan Rotavirus Infections Drug Revenue by Company (2016-2021)
9.2 Japan Rotavirus Infections Drug Sales Breakdown by Type
9.2.1 Japan Rotavirus Infections Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Rotavirus Infections Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Rotavirus Infections Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Rotavirus Infections Drug Market Facts & Figures
10.1 Southeast Asia Rotavirus Infections Drug Sales by Company
10.1.1 Southeast Asia Rotavirus Infections Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Rotavirus Infections Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Rotavirus Infections Drug Sales Breakdown by Type
10.2.1 Southeast Asia Rotavirus Infections Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Rotavirus Infections Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Rotavirus Infections Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)
11 India Rotavirus Infections Drug Market Facts & Figures
11.1 India Rotavirus Infections Drug Sales by Company
11.1.1 India Rotavirus Infections Drug Sales by Company (2016-2021)
11.1.2 India Rotavirus Infections Drug Revenue by Company (2016-2021)
11.2 India Rotavirus Infections Drug Sales Breakdown by Type
11.2.1 India Rotavirus Infections Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Rotavirus Infections Drug Sales Breakdown by Type (2022-2027)
11.3 India Rotavirus Infections Drug Sales Breakdown by Application
11.3.1 India Rotavirus Infections Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Rotavirus Infections Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Rotavirus Infections Drug Business
12.1 Beijing Minhai Biotechnology Co Ltd
12.1.1 Beijing Minhai Biotechnology Co Ltd Corporation Information
12.1.2 Beijing Minhai Biotechnology Co Ltd Business Overview
12.1.3 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Products Offered
12.1.5 Beijing Minhai Biotechnology Co Ltd Recent Development
12.2 Bharat Biotech International Ltd
12.2.1 Bharat Biotech International Ltd Corporation Information
12.2.2 Bharat Biotech International Ltd Business Overview
12.2.3 Bharat Biotech International Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bharat Biotech International Ltd Rotavirus Infections Drug Products Offered
12.2.5 Bharat Biotech International Ltd Recent Development
12.3 Biological E Ltd
12.3.1 Biological E Ltd Corporation Information
12.3.2 Biological E Ltd Business Overview
12.3.3 Biological E Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Biological E Ltd Rotavirus Infections Drug Products Offered
12.3.5 Biological E Ltd Recent Development
12.4 Curevac AG
12.4.1 Curevac AG Corporation Information
12.4.2 Curevac AG Business Overview
12.4.3 Curevac AG Rotavirus Infections Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Curevac AG Rotavirus Infections Drug Products Offered
12.4.5 Curevac AG Recent Development
12.5 Medicago Inc
12.5.1 Medicago Inc Corporation Information
12.5.2 Medicago Inc Business Overview
12.5.3 Medicago Inc Rotavirus Infections Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Medicago Inc Rotavirus Infections Drug Products Offered
12.5.5 Medicago Inc Recent Development
12.6 Nanotherapeutics Inc
12.6.1 Nanotherapeutics Inc Corporation Information
12.6.2 Nanotherapeutics Inc Business Overview
12.6.3 Nanotherapeutics Inc Rotavirus Infections Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Nanotherapeutics Inc Rotavirus Infections Drug Products Offered
12.6.5 Nanotherapeutics Inc Recent Development
12.7 Serum Institute of India Ltd
12.7.1 Serum Institute of India Ltd Corporation Information
12.7.2 Serum Institute of India Ltd Business Overview
12.7.3 Serum Institute of India Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Serum Institute of India Ltd Rotavirus Infections Drug Products Offered
12.7.5 Serum Institute of India Ltd Recent Development
12.8 UMN Pharma Inc
12.8.1 UMN Pharma Inc Corporation Information
12.8.2 UMN Pharma Inc Business Overview
12.8.3 UMN Pharma Inc Rotavirus Infections Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 UMN Pharma Inc Rotavirus Infections Drug Products Offered
12.8.5 UMN Pharma Inc Recent Development
12.9 Wuhan Institute of Biological Products Co Ltd
12.9.1 Wuhan Institute of Biological Products Co Ltd Corporation Information
12.9.2 Wuhan Institute of Biological Products Co Ltd Business Overview
12.9.3 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Products Offered
12.9.5 Wuhan Institute of Biological Products Co Ltd Recent Development
13 Rotavirus Infections Drug Manufacturing Cost Analysis
13.1 Rotavirus Infections Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Rotavirus Infections Drug
13.4 Rotavirus Infections Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Rotavirus Infections Drug Distributors List
14.3 Rotavirus Infections Drug Customers
15 Market Dynamics
15.1 Rotavirus Infections Drug Market Trends
15.2 Rotavirus Infections Drug Drivers
15.3 Rotavirus Infections Drug Market Challenges
15.4 Rotavirus Infections Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Rotavirus Infections Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Rotavirus Infections Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Rotavirus Infections Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Rotavirus Infections Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global Rotavirus Infections Drug Sales Market Share by Region (2016-2021)
Table 6. Global Rotavirus Infections Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Rotavirus Infections Drug Revenue Share by Region (2016-2021)
Table 8. Global Rotavirus Infections Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Rotavirus Infections Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Rotavirus Infections Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Rotavirus Infections Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Rotavirus Infections Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Rotavirus Infections Drug Sales Share by Company (2016-2021)
Table 14. Global Rotavirus Infections Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Rotavirus Infections Drug Revenue Share by Company (2016-2021)
Table 16. Global Rotavirus Infections Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rotavirus Infections Drug as of 2020)
Table 17. Global Rotavirus Infections Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Rotavirus Infections Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Rotavirus Infections Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Rotavirus Infections Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global Rotavirus Infections Drug Sales Share by Type (2016-2021)
Table 23. Global Rotavirus Infections Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Rotavirus Infections Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Rotavirus Infections Drug Sales Share by Type (2022-2027)
Table 26. Global Rotavirus Infections Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Rotavirus Infections Drug Revenue Share by Type (2022-2027)
Table 28. Global Rotavirus Infections Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Rotavirus Infections Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global Rotavirus Infections Drug Sales Share by Application (2016-2021)
Table 31. Global Rotavirus Infections Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Rotavirus Infections Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Rotavirus Infections Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global Rotavirus Infections Drug Sales Share by Application (2022-2027)
Table 35. Global Rotavirus Infections Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Rotavirus Infections Drug Revenue Share by Application (2022-2027)
Table 37. Global Rotavirus Infections Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Rotavirus Infections Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America Rotavirus Infections Drug Sales Market Share by Company (2016-2021)
Table 40. North America Rotavirus Infections Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Rotavirus Infections Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Rotavirus Infections Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Rotavirus Infections Drug Sales Market Share by Type (2016-2021)
Table 44. North America Rotavirus Infections Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Rotavirus Infections Drug Sales Market Share by Type (2022-2027)
Table 46. North America Rotavirus Infections Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Rotavirus Infections Drug Sales Market Share by Application (2016-2021)
Table 48. North America Rotavirus Infections Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Rotavirus Infections Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Rotavirus Infections Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Rotavirus Infections Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Rotavirus Infections Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Rotavirus Infections Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Rotavirus Infections Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Rotavirus Infections Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Rotavirus Infections Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Rotavirus Infections Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Rotavirus Infections Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Rotavirus Infections Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Rotavirus Infections Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Rotavirus Infections Drug Sales Market Share by Application (2022-2027)
Table 62. China Rotavirus Infections Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China Rotavirus Infections Drug Sales Market Share by Company (2016-2021)
Table 64. China Rotavirus Infections Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Rotavirus Infections Drug Revenue Market Share by Company (2016-2021)
Table 66. China Rotavirus Infections Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China Rotavirus Infections Drug Sales Market Share by Type (2016-2021)
Table 68. China Rotavirus Infections Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China Rotavirus Infections Drug Sales Market Share by Type (2022-2027)
Table 70. China Rotavirus Infections Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China Rotavirus Infections Drug Sales Market Share by Application (2016-2021)
Table 72. China Rotavirus Infections Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China Rotavirus Infections Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Rotavirus Infections Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Rotavirus Infections Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Rotavirus Infections Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Rotavirus Infections Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Rotavirus Infections Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Rotavirus Infections Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Rotavirus Infections Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Rotavirus Infections Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Rotavirus Infections Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Rotavirus Infections Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Rotavirus Infections Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Rotavirus Infections Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Rotavirus Infections Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Rotavirus Infections Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Rotavirus Infections Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Rotavirus Infections Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Rotavirus Infections Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Rotavirus Infections Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Rotavirus Infections Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Rotavirus Infections Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Rotavirus Infections Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Rotavirus Infections Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Rotavirus Infections Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Rotavirus Infections Drug Sales Market Share by Application (2022-2027)
Table 98. India Rotavirus Infections Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India Rotavirus Infections Drug Sales Market Share by Company (2016-2021)
Table 100. India Rotavirus Infections Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Rotavirus Infections Drug Revenue Market Share by Company (2016-2021)
Table 102. India Rotavirus Infections Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India Rotavirus Infections Drug Sales Market Share by Type (2016-2021)
Table 104. India Rotavirus Infections Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India Rotavirus Infections Drug Sales Market Share by Type (2022-2027)
Table 106. India Rotavirus Infections Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India Rotavirus Infections Drug Sales Market Share by Application (2016-2021)
Table 108. India Rotavirus Infections Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India Rotavirus Infections Drug Sales Market Share by Application (2022-2027)
Table 110. Beijing Minhai Biotechnology Co Ltd Corporation Information
Table 111. Beijing Minhai Biotechnology Co Ltd Description and Business Overview
Table 112. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product
Table 114. Beijing Minhai Biotechnology Co Ltd Recent Development
Table 115. Bharat Biotech International Ltd Corporation Information
Table 116. Bharat Biotech International Ltd Description and Business Overview
Table 117. Bharat Biotech International Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Bharat Biotech International Ltd Rotavirus Infections Drug Product
Table 119. Bharat Biotech International Ltd Recent Development
Table 120. Biological E Ltd Corporation Information
Table 121. Biological E Ltd Description and Business Overview
Table 122. Biological E Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Biological E Ltd Rotavirus Infections Drug Product
Table 124. Biological E Ltd Recent Development
Table 125. Curevac AG Corporation Information
Table 126. Curevac AG Description and Business Overview
Table 127. Curevac AG Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Curevac AG Rotavirus Infections Drug Product
Table 129. Curevac AG Recent Development
Table 130. Medicago Inc Corporation Information
Table 131. Medicago Inc Description and Business Overview
Table 132. Medicago Inc Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Medicago Inc Rotavirus Infections Drug Product
Table 134. Medicago Inc Recent Development
Table 135. Nanotherapeutics Inc Corporation Information
Table 136. Nanotherapeutics Inc Description and Business Overview
Table 137. Nanotherapeutics Inc Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Nanotherapeutics Inc Rotavirus Infections Drug Product
Table 139. Nanotherapeutics Inc Recent Development
Table 140. Serum Institute of India Ltd Corporation Information
Table 141. Serum Institute of India Ltd Description and Business Overview
Table 142. Serum Institute of India Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Serum Institute of India Ltd Rotavirus Infections Drug Product
Table 144. Serum Institute of India Ltd Recent Development
Table 145. UMN Pharma Inc Corporation Information
Table 146. UMN Pharma Inc Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. UMN Pharma Inc Description and Business Overview
Table 148. UMN Pharma Inc Rotavirus Infections Drug Product
Table 149. UMN Pharma Inc Recent Development
Table 150. Wuhan Institute of Biological Products Co Ltd Corporation Information
Table 151. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Wuhan Institute of Biological Products Co Ltd Description and Business Overview
Table 153. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product
Table 154. Wuhan Institute of Biological Products Co Ltd Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Rotavirus Infections Drug Distributors List
Table 158. Rotavirus Infections Drug Customers List
Table 159. Rotavirus Infections Drug Market Trends
Table 160. Rotavirus Infections Drug Market Drivers
Table 161. Rotavirus Infections Drug Market Challenges
Table 162. Rotavirus Infections Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Rotavirus Infections Drug Product Picture
Figure 2. Global Rotavirus Infections Drug Sales Market Share by Type in 2021 & 2027
Figure 3. RV-3BB Product Picture
Figure 4. RV-625 Product Picture
Figure 5. UMN-2001 Product Picture
Figure 6. Rotavac-5C Product Picture
Figure 7. Others Product Picture
Figure 8. Global Rotavirus Infections Drug Sales Market Share by Application in 2021 & 2027
Figure 9. Clinic Examples
Figure 10. Hospital Examples
Figure 11. Others Examples
Figure 12. Global Rotavirus Infections Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Rotavirus Infections Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Rotavirus Infections Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 15. Global Rotavirus Infections Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 16. Global Rotavirus Infections Drug Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Rotavirus Infections Drug Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Rotavirus Infections Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Rotavirus Infections Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 20. Europe Rotavirus Infections Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Rotavirus Infections Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Rotavirus Infections Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Rotavirus Infections Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Rotavirus Infections Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Rotavirus Infections Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Rotavirus Infections Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Rotavirus Infections Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Rotavirus Infections Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Rotavirus Infections Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Rotavirus Infections Drug Players Market Share by Revenue in Rotavirus Infections Drug: 2016 & 2020
Figure 31. Rotavirus Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Rotavirus Infections Drug Revenue Share by Type (2016-2021)
Figure 33. Global Rotavirus Infections Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Rotavirus Infections Drug Revenue Share by Application (2016-2021)
Figure 35. Global Rotavirus Infections Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Rotavirus Infections Drug Sales Market Share by Type in 2020
Figure 37. North America Rotavirus Infections Drug Sales Market Share by Application in 2020
Figure 38. Europe Rotavirus Infections Drug Sales Market Share by Type in 2020
Figure 39. Europe Rotavirus Infections Drug Sales Market Share by Application in 2020
Figure 40. China Rotavirus Infections Drug Sales Market Share by Type in 2020
Figure 41. China Rotavirus Infections Drug Sales Market Share by Application in 2020
Figure 42. Japan Rotavirus Infections Drug Sales Market Share by Type in 2020
Figure 43. Japan Rotavirus Infections Drug Sales Market Share by Application in 2020
Figure 44. Southeast Asia Rotavirus Infections Drug Sales Market Share by Type in 2020
Figure 45. Southeast Asia Rotavirus Infections Drug Sales Market Share by Application in 2020
Figure 46. India Rotavirus Infections Drug Sales Market Share by Type in 2020
Figure 47. India Rotavirus Infections Drug Sales Market Share by Application in 2020
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Rotavirus Infections Drug
Figure 50. Manufacturing Process Analysis of Rotavirus Infections Drug
Figure 51. Rotavirus Infections Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs